200 related articles for article (PubMed ID: 21143974)
1. In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine.
Vilekar P; Awasthi V; Lagisetty P; King C; Shankar N; Awasthi S
BMC Immunol; 2010 Dec; 11():60. PubMed ID: 21143974
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii.
Awasthi S; Awasthi V; Magee DM; Coalson JJ
J Immunol; 2005 Sep; 175(6):3900-6. PubMed ID: 16148136
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-based immunization induces Coccidioides Ag2/PRA-specific immune response.
Awasthi S; Vilekar P; Conkleton A; Rahman N
Vaccine; 2019 Mar; 37(12):1685-1691. PubMed ID: 30795939
[TBL] [Abstract][Full Text] [Related]
4. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
Jiang C; Magee DM; Ivey FD; Cox RA
Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
[TBL] [Abstract][Full Text] [Related]
5. Intranasal Antifungal Vaccination Using DNA-Transfected Dendritic Cells.
Awasthi S
Methods Mol Biol; 2017; 1625():75-83. PubMed ID: 28584984
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
Herr RA; Hung CY; Cole GT
Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
[TBL] [Abstract][Full Text] [Related]
7. Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection.
Hung CY; Wozniak KL; Cole GT
Methods Mol Biol; 2016; 1403():551-66. PubMed ID: 27076153
[TBL] [Abstract][Full Text] [Related]
8. Coccidioidomycosis: host response and vaccine development.
Cox RA; Magee DM
Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
[TBL] [Abstract][Full Text] [Related]
9. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
[TBL] [Abstract][Full Text] [Related]
10. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.
Jiang C; Magee DM; Cox RA
Infect Immun; 1999 Nov; 67(11):5848-53. PubMed ID: 10531239
[TBL] [Abstract][Full Text] [Related]
11. Cholera vaccine candidate 638: intranasal immunogenicity and expression of a foreign antigen from the pulmonary pathogen Coccidioides immitis.
Silva AJ; Mohan A; Benitez JA
Vaccine; 2003 Dec; 21(32):4715-21. PubMed ID: 14585681
[TBL] [Abstract][Full Text] [Related]
12. Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae.
Silva AJ; Benitez JA
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):393-8. PubMed ID: 15708313
[TBL] [Abstract][Full Text] [Related]
13. Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice.
Peng T; Shubitz L; Simons J; Perrill R; Orsborn KI; Galgiani JN
Infect Immun; 2002 Jul; 70(7):3330-5. PubMed ID: 12065470
[TBL] [Abstract][Full Text] [Related]
14. Vaccinated C57BL/6 mice develop protective and memory T cell responses to Coccidioides posadasii infection in the absence of interleukin-10.
Hung CY; Castro-Lopez N; Cole GT
Infect Immun; 2014 Feb; 82(2):903-13. PubMed ID: 24478103
[TBL] [Abstract][Full Text] [Related]
15. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
Jiang C; Magee DM; Quitugua TN; Cox RA
Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
[TBL] [Abstract][Full Text] [Related]
16. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.
Shubitz L; Peng T; Perrill R; Simons J; Orsborn K; Galgiani JN
Infect Immun; 2002 Jun; 70(6):3287-9. PubMed ID: 12011027
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell-based vaccine against coccidioides infection.
Awasthi S
Ann N Y Acad Sci; 2007 Sep; 1111():269-74. PubMed ID: 17363430
[TBL] [Abstract][Full Text] [Related]
18. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
19. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.
Hurtgen BJ; Hung CY; Ostroff GR; Levitz SM; Cole GT
Infect Immun; 2012 Nov; 80(11):3960-74. PubMed ID: 22949556
[TBL] [Abstract][Full Text] [Related]
20. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice.
Fierer J; Waters C; Walls L
J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]